Spent a little time this morning trying to find out a little about koneksa and the significance of the partnership.
Was glad to see they deal with some of the major global companies with Merck global health being an investor in them and that they are a partner with Apple for trials with the Apple Watch.
All probably insignificant to Uscom other than reassuring that you would presume they would not have committed to a partnership with a tiny Australian company if they didn’t feel the spirosonic had potential.
Reassuring but means nothing without future large sales success but the potential is there in what is a huge and growing spirometry market.
News: UCM Uscom Ltd Announces Extension Of Its Ongoing Partnership With Koneksa, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable